Search results
UPDATE 1-Pfizer agrees to settle over 10,000 Zantac lawsuits, Bloomberg News reports
Reuters via Yahoo Finance· 2 days agoPfizer has agreed to settle more than 10,000 lawsuits about cancer risks related to the now discontinued heartburn drug Zantac, Bloomberg News reported on Wednesday, citing ...
Spotlight on Pfizer: Analyzing the Surge in Options Activity - Pfizer (NYSE:PFE)
Benzinga· 12 hours agoSerious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely. If you want to stay ...
Pfizer Agrees to Settle More than 10,000 Zantac Cancer Lawsuits
Bloomberg· 2 days agoPfizer Inc. has agreed to settle more than 10,000 cases accusing it of hiding the cancer risks of...
Pfizer pauses phase 3 dosing in gene therapy trial after young boy's death
FierceBiotech· 3 days agoA young boy with Duchenne muscular dystrophy (DMD) participating in Pfizer’s phase 2 gene therapy...
This 6% Yielding Dividend Stock Could Pump Up Your Passive-Income Stream
Motley Fool via Yahoo Finance· 1 day agoAdvisor analyst team just identified what they believe are the 10 best stocks for investors to buy...
Do These 3 Checks Before Buying Pfizer Inc. (NYSE:PFE) For Its Upcoming Dividend
Simply Wall St. via Yahoo Finance· 6 days agoIt's good to see both earnings and the dividend have improved - although the former has been rising...
Pfizer reports patient death in Duchenne gene therapy study
Reuters· 2 days ago, opens new tab experimental gene therapy being tested in a mid-stage trial for a muscle-wasting...
Can Pfizer Challenge Lilly and Novo Nordisk in the Obesity Market?
Motley Fool via Yahoo Finance· 6 days agoAdvisor analyst team just identified what they believe are the 10 best stocks for investors to buy...
2 No-Brainer Dividend Stocks to Buy in May
Motley Fool via Yahoo Finance· 21 hours agoFor investors looking for deep value, Pfizer's stock, trading at just 12.7x forward earnings, represents a tremendous opportunity. And with the company's...
Pfizer Announces New Chief Strategy and Innovation Officer
Morningstar· 4 days agoPfizer Inc. (NYSE: PFE) today announced that Andrew Baum, M.D., will join the company as Chief Strategy and Innovation Officer, Executive Vice President. Dr. Baum will be ...